FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

7717611000001106: Ospolot 200mg tablets (Bayer Plc) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
20640101000001114 Ospolot 200mg tablets (Bayer Plc) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
43161601000001115 Ospolot 200mg tablets (Imported (Germany)) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Ospolot 200mg tablets (Bayer Plc) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Ospolot 200mg tablets (Bayer Plc) Is a Sultiame 200mg tablets true Inferred relationship Existential restriction modifier
Ospolot 200mg tablets (Bayer Plc) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction imported true Inferred relationship Existential restriction modifier
Ospolot 200mg tablets (Bayer Plc) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Ospolot 200mg tablets (Bayer Plc) Has active ingredient Sulthiamine true Inferred relationship Existential restriction modifier
Ospolot 200mg tablets (Bayer Plc) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Ospolot 200mg tablets (Bayer Plc) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Ospolot 200mg tablets (Bayer Plc) Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Ospolot 200mg tablets (Bayer Plc) Has specific active ingredient Sulthiamine true Inferred relationship Existential restriction modifier
Ospolot 200mg tablets (Bayer Plc) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Ospolot 200mg tablets (Bayer Plc) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Ospolot 200mg tablets (Bayer Plc) Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Ospolot 200mg tablets (Bayer Plc) 50 tablet Is pack of False Ospolot 200mg tablets (Bayer Plc) Inferred relationship Existential restriction modifier
Ospolot 200mg tablets (Bayer Plc) 50 tablet Has AMP True Ospolot 200mg tablets (Bayer Plc) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start